Jan 15, 2009 - Oscient Pharmaceuticals Corporation today announced that it, its wholly owned subsidiary Guardian II Acquisition Corporation, and its licensor, Ethypharm SA, have filed a lawsuit against Lupin Limited and its subsidiary Lupin Pharmaceuticals, Inc. in the United States District Court for the District of Maryland for infringement of U.S. Patent No. 7,101,574, which covers ANTARA (fenofibrate) capsules.
The details can be read here.
No comments:
Post a Comment